Susceptibility of Organisms in the <i>Mycobacterium fortuitum</i> Complex to Antituberculous and Other Antimicrobial Agents

Abstract

Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.